Trial Profile
Emicizumab for the treatment of Haemophilia A
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 01 Dec 2018
Price :
$35
*
At a glance
- Drugs Emicizumab (Primary) ; Eptacog alfa; Factor VIII inhibitor bypassing fraction
- Indications Haemophilia A
- Focus Therapeutic Use
- 01 Dec 2018 New trial record
- 14 Nov 2018 Results presented at the 21st Annual European Congress of the International Society for Pharmacoeconomics and Outcomes Research